Major Shareholder Announcement
(WorldNews Japan)

Genmab A/S Major shareholder announcements Major Shareholder Announcement Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; July 3, 2020 - Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Soci&eaigu;t&eaigu; G&eaigu;n&eaigu;rale S.A. has informed us that, as of June 29, 2020, Soci&eaigu;t&eaigu; G&eaigu;n&eaigu;rale S.A. through shares and financial instruments controls the voting rights to 3,285,165 shares in Genmab A/S, which amounts to 5.03% of the share capital and voting rights in Genmab A/S. About Genmab Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody...